Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modulation of opiate reward by NK1 antagonism
2007-004912-30Phase 2Terminated
- Sponsor
- Karolinska Institutet
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aprepitant in opioid use disorder (OUD), sponsored by Karolinska Institutet. Primary endpoint: Subjective psychological responses to opiate challenge. Started Oct 2007; status: terminated.
02
Drugs
aprepitant
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2007-004912-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004912-30.